Brain Imaging in COVID-19.

Published in: ACS chemical neuroscience (2021)

Considering the neurological and neuropsychiatric manifestations of coronavirus disease 2019 (COVID-19), its early diagnosis is crucial. This Viewpoint aims to highlight these manifestations through multimodal neuroimaging studies reflecting neurochemical and structural impairment.

Keyphrases

coronavirus disease
respiratory syndrome coronavirus
sars cov
high resolution
cerebral ischemia
pain management
brain injury
subarachnoid hemorrhage